|
MOBKL1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63158375698913E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.66133814775094E-14 |
| Normal-vs-Stage2 |
1.49960044382169E-10 |
| Normal-vs-Stage3 |
1.90469862104692E-12 |
| Normal-vs-Stage4 |
1.77049999994239E-07 |
| Stage1-vs-Stage2 |
8.743800E-01 |
| Stage1-vs-Stage3 |
6.307600E-01 |
| Stage1-vs-Stage4 |
9.108000E-01 |
| Stage2-vs-Stage3 |
7.818800E-01 |
| Stage2-vs-Stage4 |
9.457600E-01 |
| Stage3-vs-Stage4 |
8.877200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.99360577730113E-15 |
| Normal-vs-AfricanAmerican |
7.60049999604107E-08 |
| Normal-vs-Asian |
1.95796999999942E-05 |
| Caucasian-vs-AfricanAmerican |
2.785400E-01 |
| Caucasian-vs-Asian |
9.989600E-01 |
| AfricanAmerican-vs-Asian |
6.695200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63213886850144E-12 |
| Normal-vs-Female |
5.07639486002631E-11 |
| Male-vs-Female |
4.176800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.239800E-03 |
| Normal-vs-Extreme_Weight |
1.46759999708479E-08 |
| Normal-vs-Obese |
<1E-12 |
| Normal-vs-Extreme_Obese |
6.800700E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.193200E-01 |
| Normal_Weight-vs-Obese |
2.747400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.544600E-01 |
| Extreme_Weight-vs-Obese |
9.427200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.755000E-01 |
| Obese-vs-Extreme_Obese |
3.306400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.58779989156699E-10 |
| Normal-vs-Age(41-60Yrs) |
1.64346314335262E-12 |
| Normal-vs-Age(61-80Yrs) |
1.06289976820051E-10 |
| Normal-vs-Age(81-100Yrs) |
1.96680449704445E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.534000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.142000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.857850E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.475000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.149700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.574100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62581059726108E-12 |
| Normal-VS-Type2 PRCC |
4.44050000003582E-06 |
| Normal-VS-KIRP CIMP |
3.58459995020155E-09 |
| Normal-VS-Unclassified PRCC |
1.87372339865988E-12 |
| Type1 PRCC-VS-Type2 PRCC |
7.221900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.692000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.984400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.301600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.524400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.418000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.59460000759282E-10 |
| Normal-vs-N2 |
3.39540000005023E-06 |
| N0-vs-N1 |
5.635200E-01 |
| N0-vs-N2 |
4.563200E-01 |
| N1-vs-N2 |
3.694000E-01 |
|
|
